Cardiac AI Monitoring And Diagnostics Market Research 2024-2033: Outlook, Overview, and Competitor Analysis

"Exploring the Global Cardiac AI Monitoring And Diagnostics Market: A Comprehensive Overview

Insights into Cardiac AI Monitoring And Diagnostics Market: Global Trends and Analysis

Cardiac AI Monitoring And Diagnostics Industry - Key Market Dynamics and Trends

The cardiac AI monitoring and diagnostics market size has grown exponentially in recent years. It will grow from $1.35 billion in 2023 to $1.71 billion in 2024 at a compound annual growth rate (CAGR) of 26.6%. The growth in the historic period can be attributed to aging population demographics, rise in remote patient monitoring, increased healthcare expenditure, clinical research and validation studies, focus on preventive healthcare.

The cardiac AI monitoring and diagnostics market size is expected to see exponential growth in the next few years. It will grow to $4.37 billion in 2028 at a compound annual growth rate (CAGR) of 26.4%. The growth in the forecast period can be attributed to expansion of wearable and IoT devices, increasing adoption of telemedicine and remote monitoring, integration of big data analytics and predictive modeling, focus on patient-centered care and remote patient engagement, healthcare infrastructure development. Major trends in the forecast period include integration of AI with wearable devices, personalized risk assessment and treatment planning, predictive analytics for cardiovascular events, integration of multimodal data sources, interoperability and data integration standards.

Market Overview -
Cardiac AI monitoring and diagnostics refer to the application of artificial intelligence (AI) technologies in the field of cardiology to monitor and diagnose various cardiovascular conditions. This involves the use of advanced algorithms and machine learning techniques to analyze data from cardiac monitoring devices, such as electrocardiograms (ECGs).

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=13820&type=smp

Role Of Cardiac AI Monitoring And Diagnostics In Addressing The Rising Prevalence Of Cardiovascular Diseases
The growing prevalence of cardiovascular diseases is expected to propel the growth of cardiac AI monitoring and diagnostics going forward. Cardiovascular diseases (CVDs) are a set of illnesses of the heart and blood arteries, comprising cerebrovascular disease, coronary heart disease, rheumatic heart disease, and others. Cardiac AI monitoring and diagnostics help in early diagnosis, risk assessment, and tailored therapy of cardiovascular illnesses, resulting in better patient outcomes. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, the number of people who died from heart disease in the US increased from 690,882 in 2020 to 695,000 in 2021. Therefore, the growing prevalence of cardiovascular diseases is driving the cardiac AI monitoring and diagnostics market.

Competitive Landscape -
Major companies operating in the cardiac ai monitoring and diagnostics market report are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.

Revolutionizing Cardiac Care Advancements In Artificial Intelligence-Based Implantable Cardiac Monitors
Major companies operating in the cardiac AI monitoring and diagnostics market are focused on developing technology-based medical devices, such as artificial intelligence-based implantable cardiac monitors, to strengthen their position in the market. Artificial intelligence-based implantable cardiac monitors are devices that constantly track cardiac function. For instance, in May 2023, Biotronik, a Germany-based cardiovascular biomedical research and technology company, announced that the US Food and Drug Administration (FDA) had approved the BIOMONITOR IV implantable cardiac monitor (ICM). The BIOMONITOR IV implantable cardiac monitor (ICM) uses BIOTRONIK's innovative, AI-powered SmartECG algorithm, which contains advanced algorithms that eliminate 86% of all false identifications while maintaining 98% of real episodes. This revolutionary technology improves detection accuracy for healthcare professionals, minimizing false positive warnings and assisting them in making quick and precise diagnoses of certain cardiac problems. Aside from SmartECG technology, BIOMONITOR IV is the first ICM to distinguish between premature ventricular contractions (PVCs) and premature atrial contractions (PACs).

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/cardiac-ai-monitoring-and-diagnostics-global-market-report

Key Segments -

The cardiac ai monitoring and diagnostics market covered in this report is segmented -
1) By Type: Cardiac Diagnostics, Cardiac Monitoring
2) By Product: Software, Hardware
3) By Application: Ischemic Heart Diseases Or Coronary Artery Disease (CAD), Cardiac Arrhythmias, Ischemic Stroke, Other Applications
4) By End Users: Hospitals, Diagnostic Centers, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

"Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

"Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps"

This release was published on openPR.